These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35097226)

  • 1. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.
    Bagley AF; Ludmir EB; Maitra A; Minsky BD; Li Smith G; Das P; Koong AC; Holliday EB; Taniguchi CM; Katz MHG; Tamm EP; Wolff RA; Overman MJ; Patel S; Kim MP; Tzeng CD; Ikoma N; Bhutani MS; Koay EJ
    Clin Transl Radiat Oncol; 2022 Mar; 33():66-69. PubMed ID: 35097226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx.
    Hoffmann C; Calugaru V; Borcoman E; Moreno V; Calvo E; Liem X; Salas S; Doger B; Jouffroy T; Mirabel X; Rodriguez J; Chilles A; Bernois K; Dimitriu M; Fakhry N; Hee Kam SW; Le Tourneau C
    Eur J Cancer; 2021 Mar; 146():135-144. PubMed ID: 33607477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial.
    Bonvalot S; Rutkowski PL; Thariat J; Carrère S; Ducassou A; Sunyach MP; Agoston P; Hong A; Mervoyer A; Rastrelli M; Moreno V; Li RK; Tiangco B; Herraez AC; Gronchi A; Mangel L; Sy-Ortin T; Hohenberger P; de Baère T; Le Cesne A; Helfre S; Saada-Bouzid E; Borkowska A; Anghel R; Co A; Gebhart M; Kantor G; Montero A; Loong HH; Vergés R; Lapeire L; Dema S; Kacso G; Austen L; Moureau-Zabotto L; Servois V; Wardelmann E; Terrier P; Lazar AJ; Bovée JVMG; Le Péchoux C; Papai Z
    Lancet Oncol; 2019 Aug; 20(8):1148-1159. PubMed ID: 31296491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.
    Bonvalot S; Le Pechoux C; De Baere T; Kantor G; Buy X; Stoeckle E; Terrier P; Sargos P; Coindre JM; Lassau N; Ait Sarkouh R; Dimitriu M; Borghi E; Levy L; Deutsch E; Soria JC
    Clin Cancer Res; 2017 Feb; 23(4):908-917. PubMed ID: 27998887
    [No Abstract]   [Full Text] [Related]  

  • 5. Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.
    Bonvalot S; Rutkowski PL; Thariat J; Carrère S; Ducassou A; Sunyach MP; Agoston P; Hong AM; Mervoyer A; Rastrelli M; Moreno V; Li RK; Tiangco BJ; Herráez AC; Gronchi A; Sy-Ortin T; Hohenberger P; de Baère T; Cesne AL; Helfre S; Saada-Bouzid E; Anghel RM; Kantor G; Montero A; Loong HH; Vergés R; Kacso G; Austen L; Servois VF; Wardelmann E; Dimitriu M; Said P; Lazar AJ; Bovée JVMG; Péchoux CL; Pápai Z
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):422-432. PubMed ID: 35850363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models.
    Zhang P; Marill J; Darmon A; Mohamed Anesary N; Lu B; Paris S
    Int J Nanomedicine; 2021; 16():2761-2773. PubMed ID: 33880022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endobronchial ultrasound-guided injection of NBTXR3 radio-enhancing nanoparticles into mediastinal and hilar lymph nodes: a swine model to evaluate feasibility, injection technique, safety, nanoparticle retention and dispersion.
    Casal RF; Schwalk AJ; Fowlkes N; Aburto RR; Norton W; Dixon KA; Lin S; Shaitelman SF; Chintalapani G; Hill L
    J Thorac Dis; 2020 May; 12(5):2317-2324. PubMed ID: 32642136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New use of metals as nanosized radioenhancers.
    Pottier A; Borghi E; Levy L
    Anticancer Res; 2014 Jan; 34(1):443-53. PubMed ID: 24403500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.
    Hu Y; Paris S; Bertolet G; Barsoumian HB; Wang Q; Da Silva J; Patel NB; Nguyen N; Doss DJ; Huang A; Hsu E; Leyton CSK; Voss TA; Masrorpour F; Leuschner C; Pietz JT; Puebla-Osorio N; Gandhi S; Nguyen QN; Wang J; Cortez MA; Welsh JW
    Front Immunol; 2022; 13():1022011. PubMed ID: 36405757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases.
    Ginat DT; Juloori A; Vivar OI; Farber LA; Gooi Z; Rosenberg AJ
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
    Marill J; Anesary NM; Zhang P; Vivet S; Borghi E; Levy L; Pottier A
    Radiat Oncol; 2014 Jun; 9():150. PubMed ID: 24981953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire.
    Darmon A; Zhang P; Marill J; Mohamed Anesary N; Da Silva J; Paris S
    Cancer Cell Int; 2022 Jun; 22(1):208. PubMed ID: 35659676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
    Liem X; de Baère T; Vivar OI; Seiwert TY; Shen C; Pápai Z; Moreno V; Takácsi-Nagy Z; Helfferich F; Thariat J; Gooi Z; Yom SS; Bossi P; Ferris RL; Hackman TG; Le Tourneau C; Rodriguez J; Hoffmann C
    Head Neck; 2024 Jun; 46(6):1253-1262. PubMed ID: 38600434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model.
    Hu Y; Paris S; Barsoumian H; Abana CO; He K; Sezen D; Wasley M; Masrorpour F; Chen D; Yang L; Dunn JD; Gandhi S; Nguyen QN; Cortez MA; Welsh JW
    J Nanobiotechnology; 2021 Dec; 19(1):416. PubMed ID: 34895262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization.
    Da Silva J; Bienassis C; Schmitt P; Berjaud C; Guedj M; Paris S
    J Exp Clin Cancer Res; 2024 Jan; 43(1):11. PubMed ID: 38173001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model.
    Zhang P; Darmon A; Marill J; Mohamed Anesary N; Paris S
    Int J Nanomedicine; 2020; 15():3843-3850. PubMed ID: 32581534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
    Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study.
    Bai YR; Wu GH; Guo WJ; Wu XD; Yao Y; Chen Y; Zhou RH; Lu DQ
    World J Gastroenterol; 2003 Nov; 9(11):2561-4. PubMed ID: 14606097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.